UFP科技
UFPT
291.67
-5.52
-1.86%
UFP科技
US · UFPT
#2677 按市值排名
上市于 1970
291.67
-5.52
-1.86%
实时 - 追踪5344个代码 - 心跳于6秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了0.2个百分点。
机构持股
- 机构持股比例
- 124.99% +0.19pp
- 机构数量
- 337
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund114.55%
Hedge Fund5.35%
Individual/Insider3.42%
Public Company2.14%
Government Pension Fund1.51%
Family Office/Trust0.56%
Private Company0.45%
Insurance Company0.22%
Sovereign Wealth Fund0.13%
主要股东 截至 2026-06-30
BlackRock
14.74% · 1.14M 股
Congress Asset Management Company, LLP
8.88% · 687.44K 股
Wasatch Advisors LP
8.82% · 683.26K 股
Neuberger Berman Investment Advisers LLC
6.93% · 537.04K 股
Vanguard Capital Management, LLC
4.97% · 384.62K 股
T. Rowe Price Group, Inc.
4.61% · 357.33K 股
Boston Trust Walden National Association
4.34% · 336.28K 股
State Street Global Advisors
4.04% · 312.81K 股
American Century Investment Management
3.61% · 279.98K 股
UBS Asset Management
3.46% · 268.10K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 26次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| R. Bailly | Chairman of the Board of Directors, President & CEO | 1.74% |
| Ronald Lataille | CFO, Senior VP & Treasurer | 0.60% |
| Mitchell Rock | President of MedTech | 0.35% |
| Marc Kozin | Independent Director | 0.26% |
| Thomas Oberdorf | Independent Director | 0.16% |
| Christopher Litterio | General Counsel, Secretary & Senior VP of Human Resources | 0.11% |
| Jason Holt | VP, GM of Advanced Components & Chief Commercial Officer of MedTech | 0.07% |
| Steven Cardin | VP & COO of MedTech | 0.05% |
| Cynthia Feldmann | Independent Director | 0.05% |
| Joseph Hassett | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-24 | Marc Kozin | Independent Director | Open Market Disposition | -7,000 | $303.97–305.07 |
| 2026-08-17 | Symeria Hudson | Independent Director | Open Market Disposition | -298 | $319.11 |
| 2026-08-13 | Symeria Hudson | Independent Director | Derivative Exercise and Sale | -1,196 | $167.98–324.58 |
| 2026-08-13 | Symeria Hudson | Independent Director | Open Market Disposition | -730 | $324.58 |
| 2026-08-13 | Symeria Hudson | Independent Director | Intent to Sell (Form 144) | -2,224 | -- |
| 2026-08-12 | Cynthia Feldmann | Independent Director | Open Market Disposition | -1,000 | $324.26 |
| 2026-08-09 | R. Bailly | Chairman of the Board of Directors, President & CEO | Open Market Disposition | -13,011 | $315.53–317.27 |
| 2026-08-06 | R. Bailly | Chairman of the Board of Directors, President & CEO | Open Market Disposition | -15,695 | $315.06–320.05 |
| 2026-08-05 | Christopher Litterio | General Counsel, Secretary & Senior VP of Human Resources | Intent to Sell (Form 144) | -1,000 | $322.00 |
| 2026-08-05 | Jason Holt | VP, GM of Advanced Components & Chief Commercial Officer of MedTech | Open Market Disposition | -1,100 | $317.00 |
| 2026-06-11 | Cynthia Feldmann | Independent Director | Derivative Exercise and Sale | -1,200 | $43.95–240.40 |
| 2026-06-04 | R. Bailly | Chairman of the Board of Directors, President & CEO | Sale to Issuer | -750 | $223.87 |
| 2026-06-04 | R. Bailly | Chairman of the Board of Directors, President & CEO | Other Acquisition | +1,787 | -- |
| 2026-06-03 | Ronald Lataille | CFO, Senior VP & Treasurer | Other Acquisition | +4,454 | -- |
| 2026-06-03 | Thomas Oberdorf | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Daniel Croteau | Lead Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Marc Kozin | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Mitchell Rock | President of MedTech | Other Acquisition | +2,895 | -- |
| 2026-06-03 | Cynthia Feldmann | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Joseph Hassett | Independent Director | Other Acquisition | +802 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
UFP科技 讨论区 0 条评论